Effect of high-density lipoprotein cholesterol levels on carotid artery geometry in a Mediterranean female population

European Journal of Preventive Cardiology

Volumn 11, Issue 5, 2004, Pages 403-407

  Michele, Mario de ^a   Iannuzzi, Arcangelo ^c   Panico, Salvatore ^a   Celentano, Egidio ^d   Sacchetti, Lucia ^b   Mazzaccara, Cristina ^b   Salvato, Amalia ^a   Bond, M Gene ^e   Salvatore, Francesco ^b   Rubba, Paolo ^a  

^a Department of Clinical and Experimental Medicine ^*  (Germany)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Cava de' Tirreni Hospital   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

atherosclerosis; HDL cholesterol; oxidation markers; ultrasound; women

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY DIAMETER; ARTERY WALL; ATHEROSCLEROSIS; B SCAN; BODY MASS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GEOMETRY; HUMAN; INTIMA; ITALY; MAJOR CLINICAL STUDY; OXIDATION; PRIORITY JOURNAL; RISK FACTOR; THICKNESS;

ADULT; AGED; ARTERIOSCLEROSIS; CAROTID ARTERIES; CHOLESTEROL, HDL; COHORT STUDIES; FEMALE; HUMANS; ITALY; MIDDLE AGED; RISK FACTORS; SEX FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 8544270090     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000136417.70511.fd     Document Type: Article

References (32)

1. Miller NE, Forde OH, Thelle DS, Mjos OD. The Tromso Heart Study: high-density lipoprotein as a protective factor against coronary heart disease: a prospective case-control study. Lancet 1977; 1: 965–967.
2. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD,, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8–15.
3. Bots ML, Elwood PC, Nikitin Y, Salonen JT, Freire de Concalves A, Inzitari D,, et al. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 2002; 56(Suppl 1):i19–i24.
4. Tanne D, Yaari S, Goldbourt U. High-density lipoprotein cholesterol and risk of ischemic stroke mortality: a 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke 1997; 28: 83–87.
5. Wannamethee SG, Shaper AG, Ebrahim S. HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke 2000; 31: 1882–1888.
6. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG,, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2003; 34: 623–631.
7. Heiss G, Sharett AR, Barnes R, Chambless LE, Szklo M, Alzola C and The ARIC Investigators Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134: 250–256.
8. Folsom AR, Wu KK, Shahar E, Davis CE, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb 1993; 13: 1829–1836.
9. Hwang SJ, Ballantyne CM, Sharrett R, Smith LC, Davis CE, Gotto AM Jr,, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation 1997; 96: 4219–4225.
10. McQuillan BM, Beilby JP, Nidorf M, Thompson PL, Hung J. Hyper-homocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS). Circulation 1999; 99: 2383–2388.
11. Bots MI, Hofman A, Grobbee DE. Carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler Thromb 1994; 14: 1885–1891.
12. Crouse JR, Craven TE, Hagaman AP, Bond MG. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation 1995; 92: 1141–1147.
13. Bond MG, Wilmoth SK, Enevold GL, Strickland HL. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Am J Med 1989; 86: 33–36.
14. Mercuri M, Bond MG, Sirtori CR, Veglia F, Crepaldi G, Feruglio FS,, et al. Pravastatin reduces intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: The Carotid Italian Ultrasound Study. Am J Med 1996; 101: 627–634.
15. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C,, et al. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002; 106: 2422–2427.
16. Panico S, Dello Iacovo R, Celentano E, Galasso R, Muti P, Salvatore M,, et al. Progetto Atena, a study on the etiology of major chronic diseases in women: design, rationale and objectives. Europ J Epidemiol 1992; 8: 601–608.
17. Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for enzymatic determination of serum cholesterol. J Clin Chem Biochem 1981; 19: 838–839.
18. Wahlefeld AW. Triglyceride determination after enzymatic hydrolysis. In: Bergmeyer HU,(ed. ), Methods of enzymatic analysis. 2nd edit. Weinheim, Verlag Chemie and New York, Academic Press, 1974; vol. 4: 1831.
19. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882–884.
20. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959–965.
21. Rubba P, Panico S, Bond MG, Covetti G, Celentano E, Iannuzzi A,, et al. Site-specific atherosclerotic plaques in the carotid arteries of middle-aged women from Southern Italy. Associations with traditional risk factors and oxidation markers. Stroke 2001; 32: 1953–1959.
22. Selzer RH, Hodis HN, Kwong-Fu H, Mack WJ, Lee PL, Liu CR,, et al. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994; 111: 1–11.
23. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 20: 159–169.
24. Tang R, Hennig M, Thomasson B, Scherz R, Ravinetto R, Catalini R,, et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2000; 18: 197–201.
25. Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul PJ, Malmejac A, Guize L. Risk factors for early carotid atherosclerosis in middle-aged French women. Arteriosclerosis and Thrombosis 1991; 11: 966–972.
26. Lassila HC, Tyrell KS, Matthews KA, Wolfson SK, Kuller LH. Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women. Stroke 1997; 28: 513–517.
27. Stensland-Bugge E, Bonaa KH, Joakimsen O. Age and sex differences in the relationship between inherited and lifestyle risk factors and sub-clinical carotid atherosclerosis: the Tromso study. Atherosclerosis 2001; 154: 437–448.
28. Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 1997; 95: 1–4.
29. Linton MF, Fazio S. National Cholesterol Education Program (NCEP)- the third Adult Treatment Panel (ATP III). A practical approach to risk assessment to prevent coronary artery disease and its complications. Am J Cardiol 2003; 92: 19i–26i.
30. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990; 1044: 275–283.
31. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM,, et al. Protective effect of high-density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidized low density lipoproteins. J Clin Invest 1995; 96: 2882–2891.
32. Graham A, Hassall DG, Rafique S, Owen JS. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Atherosclerosis 1997; 135: 193–204.